Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Clinical trial NCT02947165 · COMPLETED

Trial details

NCT number: NCT02947165
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Hepatocellular Cancer Colorectal Cancer Pancreatic Cancer Renal Cancer

Start date: 2017-04-25
Primary completion: 2021-06-18
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.